Cargando…

In Vitro–In Vivo Relationship in Mini-Scale—Enabling Formulations of Corallopyronin A

In vivo studies in mice provide a valuable model to test novel active pharmaceutical ingredients due to their low material need and the fact that mice are frequently used as a species for early efficacy models. However, preclinical in vitro evaluations of formulation principles in mice are still lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Becker, Tim, Krome, Anna K., Vahdati, Sahel, Schiefer, Andrea, Pfarr, Kenneth, Ehrens, Alexandra, Aden, Tilman, Grosse, Miriam, Jansen, Rolf, Alt, Silke, Hesterkamp, Thomas, Stadler, Marc, Hübner, Marc P., Kehraus, Stefan, König, Gabriele M., Hoerauf, Achim, Wagner, Karl G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414514/ https://www.ncbi.nlm.nih.gov/pubmed/36015283 http://dx.doi.org/10.3390/pharmaceutics14081657

Ejemplares similares

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus
por: Rox, Katharina, et al.
Publicado: (2022)

Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections
por: Schiefer, Andrea, et al.
Publicado: (2020)

Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A
por: Krome, Anna K., et al.
Publicado: (2020)

The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus
por: Balansky, Jan, et al.
Publicado: (2022)

Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A
por: Edwards, Jennifer L., et al.
Publicado: (2022)

Complete Genome Sequence of the Corallopyronin A-Producing Myxobacterium Corallococcus coralloides B035
por: Bouhired, Sarah, et al.
Publicado: (2019)

Elaborations on Corallopyronin A as a Novel Treatment Strategy Against Genital Chlamydial Infections
por: Loeper, Nathalie, et al.
Publicado: (2019)

Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis
por: Ehrens, Alexandra, et al.
Publicado: (2022)

Eosinophils in filarial infections: Inducers of protection or pathology?
por: Ehrens, Alexandra, et al.
Publicado: (2022)

NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae
por: Ajendra, Jesuthas, et al.
Publicado: (2016)

The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration
por: Pfarr, Kenneth M., et al.
Publicado: (2023)

The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use
por: Pfarr, Kenneth M., et al.
Publicado: (2023)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
por: Frohberger, Stefan J., et al.
Publicado: (2019)

Quinolone-fused cyclic sulfonamide as a novel benign antifilarial agent
por: Mukherjee, Suprabhat, et al.
Publicado: (2018)

The Annotated Genome of Wolbachia from the Filarial Nematode Brugia malayi: What It Means for Progress in Antifilarial Medicine
por: Pfarr, Kenneth, et al.
Publicado: (2005)

Helminths and their implication in sepsis – a new branch of their immunomodulatory behaviour?
por: Hübner, Marc P, et al.
Publicado: (2013)

In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae
por: Hübner, Marc P., et al.
Publicado: (2019)

AmiD Is a Novel Peptidoglycan Amidase in Wolbachia Endosymbionts of Drosophila melanogaster
por: Wilmes, Miriam, et al.
Publicado: (2017)

Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children
por: Al-Obaidi, Issraa, et al.
Publicado: (2022)

S100A8/S100A9 deficiency increases neutrophil activation and protective immune responses against invading infective L3 larvae of the filarial nematode Litomosoides sigmodontis
por: Frohberger, Stefan J., et al.
Publicado: (2020)

ILC2s Control Microfilaremia During Litomosoides sigmodontis Infection in Rag2(-/-) Mice
por: Reichwald, Julia J., et al.
Publicado: (2022)

The efficacy of the benzimidazoles oxfendazole and flubendazole against Litomosoides sigmodontis is dependent on the adaptive and innate immune system
por: Risch, Frederic, et al.
Publicado: (2023)

Human filariasis—contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model
por: Risch, Frederic, et al.
Publicado: (2021)

Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds
por: Hübner, Marc P., et al.
Publicado: (2019)

Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model
por: Specht, Sabine, et al.
Publicado: (2018)

Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses
por: Layland, Laura E., et al.
Publicado: (2015)

TGFβ depletion does neither modulate acute E. coli-induced inflammatory immune responses nor impair the protective effect by chronic filarial infection
por: Buerfent, Benedikt C., et al.
Publicado: (2019)

Macrophages Mediate Increased CD8 T Cell Inflammation During Weight Loss in Formerly Obese Mice
por: Surendar, Jayagopi, et al.
Publicado: (2020)

A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs
por: Schlabe, Stefan, et al.
Publicado: (2022)

wALADin Benzimidazoles Differentially Modulate the Function of Porphobilinogen Synthase Orthologs
por: Lentz, Christian S., et al.
Publicado: (2014)

Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro
por: Hübner, Marc P., et al.
Publicado: (2020)

Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis
por: Reiter-Owona, Ingrid, et al.
Publicado: (2015)

Eosinophils and Neutrophils Eliminate Migrating Strongyloides ratti Larvae at the Site of Infection in the Context of Extracellular DNA Trap Formation
por: Ehrens, Alexandra, et al.
Publicado: (2021)

Corrigendum: Eosinophils and Neutrophils Eliminate Migrating Strongyloides ratti Larvae at the Site of Infection in the Context of Extracellular DNA Trap Formation
por: Ehrens, Alexandra, et al.
Publicado: (2022)

Lipid profiling of the filarial nematodes Onchocerca volvulus, Onchocerca ochengi and Litomosoides sigmodontis reveals the accumulation of nematode-specific ether phospholipids in the host
por: Wewer, Vera, et al.
Publicado: (2017)

Immunization with L. sigmodontis Microfilariae Reduces Peripheral Microfilaraemia after Challenge Infection by Inhibition of Filarial Embryogenesis
por: Ziewer, Sebastian, et al.
Publicado: (2012)

In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis
por: Ehrens, Alexandra, et al.
Publicado: (2020)

Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections
por: Hawryluk, Natalie, et al.
Publicado: (2022)

Frequent detection of worm movements in onchocercal nodules by ultrasonography
por: Mand, Sabine, et al.
Publicado: (2005)

Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host
por: Albers, Anna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2drr9r4u5a0edt1rirnsnd4ms6